Suppr超能文献

一种精神益生菌补充剂对抑郁症患者血清脑源性神经营养因子水平的影响:一项随机临床试验分析

Effects of a Psychobiotic Supplement on Serum Brain-derived Neurotrophic Factor Levels in Depressive Patients: A Analysis of a Randomized Clinical Trial.

作者信息

Heidarzadeh-Rad Nazanin, Gökmen-Özel Hülya, Kazemi Asma, Almasi Negin, Djafarian Kurosh

机构信息

Department of Nutrition and Dietetics, Hacettepe University Faculty of Health Sciences, Ankara, Turkey.

Nutrition Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

J Neurogastroenterol Motil. 2020 Sep 30;26(4):486-495. doi: 10.5056/jnm20079.

Abstract

BACKGROUND/AIMS: Psychobiotics are probiotics or prebiotics that, upon ingestion in adequate amounts, yield positive influence on mental health via microbiota-gut-brain axis regulation to modulate the circulating cytokines, chemokines, neurotransmitters, or neurotrophins levels. We have recently shown that a psychobiotic combination ( R0052 and R0175; CEREBIOME) significantly improved depression symptoms in patients with depression. Recent animal data suggest the influence of the gut microbiota on brain-derived neurotrophic factor (BDNF), which was shown to correlate with antidepressant response in depressive patients. Therefore, we conducted this exploratory analysis of BDNF levels to clarify the mechanism of action of this psychobiotic in our cohort.

METHODS

Our study was a double-blind, randomized controlled trial of patients with low-to-moderate depression receiving either a probiotic combination, prebiotic or placebo. From the 110 patients randomized in the trial, 78 were included in this analysis (probiotic, n = 28; prebiotic and placebo, n = 25). We compared serum BDNF levels from participants at baseline and endpoint, and assessed the Pearson correlation between depression severity and BDNF levels for each intervention.

RESULTS

We found that post-intervention BDNF levels were significantly different between groups ( < 0.001). Furthermore, BDNF levels increased significantly in the probiotic group compared to both the prebiotic ( < 0.001) and placebo groups ( = 0.021), which inversely correlated with depression severity compared to placebo (ANOVA/ANCOVA, = 0.012; Pearson, = -0.79, < 0.001). In the prebiotic group, BDNF levels reduced but not significantly compared with placebo group ( > 0.05).

CONCLUSION

Eight-week supplementation with B. longum and L. helveticus in depressive patients improved depression symptoms, possibly by increasing BDNF levels.

摘要

背景/目的:精神益生菌是益生菌或益生元,适量摄入后,可通过微生物群-肠-脑轴调节对心理健康产生积极影响,从而调节循环细胞因子、趋化因子、神经递质或神经营养因子水平。我们最近发现,一种精神益生菌组合(R0052和R0175;CEREBIOME)能显著改善抑郁症患者的抑郁症状。最近的动物数据表明肠道微生物群对脑源性神经营养因子(BDNF)有影响,而BDNF与抑郁症患者的抗抑郁反应相关。因此,我们对BDNF水平进行了这项探索性分析,以阐明该精神益生菌在我们队列中的作用机制。

方法

我们的研究是一项双盲、随机对照试验,纳入中轻度抑郁症患者,分别给予益生菌组合、益生元或安慰剂。在该试验随机分组的110例患者中,78例纳入本分析(益生菌组,n = 28;益生元组和安慰剂组,n = 25)。我们比较了参与者在基线和终点时的血清BDNF水平,并评估了每种干预措施下抑郁严重程度与BDNF水平之间的Pearson相关性。

结果

我们发现干预后各组间BDNF水平存在显著差异(< 0.001)。此外,与益生元组(< 0.001)和安慰剂组(= 0.021)相比,益生菌组的BDNF水平显著升高,与安慰剂组相比,其与抑郁严重程度呈负相关(方差分析/协方差分析,= 0.012;Pearson相关性分析,= -0.79,< 0.001)。在益生元组中,BDNF水平降低,但与安慰剂组相比无显著差异(> 0.05)。

结论

抑郁症患者补充长双歧杆菌和瑞士乳杆菌8周可改善抑郁症状,可能是通过提高BDNF水平实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c408/7547201/812920f943e1/JNM-26-455-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验